SCHEMBL32673183

SCHEMBL32673183

COc1ccccc1[C@H](Cc1ccccn1)c1c[nH]cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 6/20 0.39
AURKB Q96GD4 1/20 0.39
INCENP Q9NQS7 1/20 0.39
KDM4E B2RXH2 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2A Q12879 1/20 0.38
GRIN2B Q13224 1/20 0.38
GRIN2C Q14957 1/20 0.38
GRIN3A Q8TCU5 1/20 0.38
ALDH1A1 P00352 1/20 0.37
NPC1 O15118 2/20 0.37
LMNA P02545 2/20 0.37
RAB9A P51151 2/20 0.37
PTPRA P18433 1/20 0.37
POLB P06746 1/20 0.36
ABCB1 P08183 1/20 0.36
HTR1A P08908 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32672776 1.00 SYK (0.39) SYKAURKBINCENPKDM4EL3MBTL1
SCHEMBL32673085 0.86 PTPRA (0.36) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL32673107 0.86 PTPRA (0.36) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL32673186 0.85 SCN8A (0.38) SYKKDM4EL3MBTL1GRIN2DGRIN3B
SCHEMBL32672710 0.85 SCN8A (0.38) SYKKDM4EL3MBTL1GRIN2DGRIN3B
SCHEMBL32673094 0.82 GRIN2D (0.34) SYKGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL32672879 0.81 GRIN2D (0.37) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL32672927 0.81 GRIN2D (0.37) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL32672980 0.80 GRIN2D (0.35) SYKKDM4EGRIN2DGRIN3BGRIN1
SCHEMBL32672777 0.80 KMT2A (0.38) L3MBTL1GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260042769-A1 TRIARYL AGONISTS OF ALPHA-2 ADRENERGIC RECEPTORS ALCEPTOR THERAPEUTICS INC (US) 2026-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042769-A1 TRIARYL AGONISTS OF ALPHA-2 ADRENERGIC RECEPTORS ADRB2, ADRB1, ADRB3 SYK 876/4885AURKB 3598/4885INCENP 4133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.